stereotactic ablative radiation therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for stereotactic ablative radiation therapy, covering 2024-03-12 to 2024-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization [Phase 3]